EDmicBio Inc. logo

EDmicBio Inc.

Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human

3 employees · est. 2019 · Seoul, Korea South

VS
Tryton logo

Tryton

Pioneering stent solutions for advanced cardiovascular care across multiple countries since 2003.

29 employees · est. 2003 · Raleigh, United States

Tryton is the older company (2019 vs 2003); Tryton is the larger of the two.

Side-by-Side Comparison

EDmicBio Inc. Tryton
Founded
2019 2003 older
Headquarters
Seoul, Korea South Raleigh, United States
Employees
3 29 larger
Industry
Information Technology Health Care, Manufacturing, Medical Devices
Funding Stage
Seed Series Unknown
Total Funding
Not tracked yet $104.27M
Funding Rounds
1 6
Services
Development of 3D organ-on-a-chip platforms, Research on drug discovery, Solutions for disease treatment Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Healthcare Institutions, Research Laboratories Not tracked yet
Taxonomy
3D Bioprinting, Organ-on-a-chip, Tissue Engineering, Stent Development, Biodegradable Medical Devices, Bioink Technology, Drug Testing Platforms, 3D Printing Systems, Microfluidics, In-vitro Drug Testing, Patient-specific Drug Development, Organ Fabrication, Biochemical Environment Mimicry, New Drug Development, Animal Testing Replacement Cardiovascular Care, Stent Solutions, Healthcare Innovation, Atherosclerosis Treatment, Bifurcation Stent, Medical Technology, Invasive Cardiology, Durham, North Carolina, International Expansion
Website
edmicbio.com trytonmedical.com
EDmicBio Inc. logo

About EDmicBio Inc.

EDmicBio Inc., established in 2019 and headquartered in Korea South, is pioneering the frontier of 3D bioprinting technology. With the innovative mission to “Investigate your drug with 3D biomimicry, 3D organ-on-a-chip. We can build a better future for humans,” this startup expertly combines fields...

Tryton logo

About Tryton

Tryton Medical is a pioneering company in the realm of stent solutions for advanced cardiovascular care, operating across multiple countries since 2003. The company's flagship product, the Tryton Side Branch Stent System, is specifically tailored to tackle atherosclerotic lesions in the side branch...

We will tell you when either one moves

BounceWatch watches EDmicBio Inc. and Tryton for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at EDmicBio Inc. and Tryton — by email.

Frequently Asked Questions

EDmicBio Inc. — Investigate your drug with 3D biomimicry 3D organ-on-a-chip. We can build a better future for human. Tryton — Pioneering stent solutions for advanced cardiovascular care across multiple countries since 2003.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
EDmicBio Inc. has raised undisclosed funding while Tryton has raised $104.27M.
EDmicBio Inc. and Tryton operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare EDmicBio Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at EDmicBio Inc. on 12 Apr 2026, and Tryton on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy